[HTML][HTML] The association between polypharmacy and malnutrition (risk) in older people: a systematic review

WE Kok, EB Haverkort, YA Algra, J Mollema… - Clinical Nutrition …, 2022 - Elsevier
Background & aim Malnutrition adversely influences a broad range of physical and
psychological symptoms. Although polypharmacy is often mentioned to be associated with …

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?

T Sauerbruch, M Hennenberg, J Trebicka… - Frontiers in …, 2023 - frontiersin.org
With increasing decompensation, hyperdynamic circulatory disturbance occurs in liver
cirrhosis despite activation of vasoconstrictors. Here, the concept of a therapy with non …

Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM

KL Hayward, AL Johnson… - BMJ Open …, 2021 - bmjopengastro.bmj.com
Objective The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) cirrhosis is often underestimated in healthcare and administrative …

Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study

PC Valery, CM Bernardes, KL Hayward, G Hartel… - BMC …, 2022 - Springer
Background Optimal management of cirrhosis is complex, and patients often lack knowledge
and skills, which can affect self-management. We assessed patient knowledge about …

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies

KL Hayward, AL Johnson… - BMJ Open …, 2020 - bmjopengastro.bmj.com
ABSTRACT Objective The utility of International Classification of Diseases (ICD) codes
relies on the accuracy of clinical reporting and administrative coding, which may be …

[PDF][PDF] Improving medication‐related outcomes in chronic liver disease

KL Hayward, RA Weersink - Hepatology Communications, 2020 - Wiley Online Library
Patients with chronic liver disease (CLD) are becoming increasingly complex due to the
rising prevalence of multimorbidity and polypharmacy. Medications are often essential to …

Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations

RA Weersink, DM Burger, KL Hayward… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction: The global burden of cirrhosis is rising, and clinicians increasingly face the
challenge of safely prescribing medicines for complications of hepatic disease and …

Appropriate and potentially inappropriate medication use in decompensated cirrhosis

MJ Thomson, ASF Lok, EB Tapper - Hepatology, 2021 - journals.lww.com
Conclusions RHOF helps tumor cells resist metabolic stress through modulating the
Warburg effect and plays a critical role in promoting HCC cell migration, invasion, and EMT …

[HTML][HTML] Benefits, challenges and contributors to the introduction of new hospital-based outpatient clinic pharmacist positions

CL Snoswell, AR Cossart, B Chevalier… - Exploratory Research in …, 2022 - Elsevier
Background Pharmacists working within interprofessional teams in the outpatient setting are
well placed to address medication-related problems before and after hospital admission …

[PDF][PDF] The patient's perspective in cirrhosis: unmet supportive care needs differ by disease severity, etiology, and age

PC Valery, CM Bernardes, B Mckillen… - Hepatology …, 2021 - Wiley Online Library
Patients with cirrhosis have significant physical, psychological, and practical needs. We
documented patients' perceived need for support with these issues and the differences with …